Article
Public Response to a Proposed Field Trial of Genetically Engineered Mosquitoes in the United States
15 Aug 2017
Abstract excerpt
This study assesses public response to a proposed field trial in the United States of genetically engineered mosquito (OX513A) designed to suppress wild-type Aedes aegypti mosquitoes, which can transmit diseases such as Zika, dengue, and chikungunya.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
